PortfoliosLab logoPortfoliosLab logo
ISIN
IL0010941198
CUSIP
M6240T109
IPO Date
May 31, 2013

Highlights

Market Cap
$424.42M
Enterprise Value
$403.13M
EPS (TTM)
$0.34
PE Ratio
20.85
PEG Ratio
6.31
Total Revenue (TTM)
$181.68M
Gross Profit (TTM)
$74.77M
EBITDA (TTM)
$38.26M
Year Range
$6.50 - $9.35
Target Price
$12.00
ROA (TTM)
5.32%
ROE (TTM)
7.85%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Kamada

Performance

KMDA Performance Chart

Kamada (KMDA) is up 4.9% since the beginning of the year. At $7 per share, KMDA is trading 23.1% below its 52-week high of $9. Investors who bought $1,000 worth of KMDA shares 5 years ago would now be looking at an investment worth $1,323.


Loading charts...

S&P 500 Index

Returns By Period

Kamada (KMDA) has returned 4.93% so far this year and 2.89% over the past 12 months. Over the last ten years, KMDA has returned 7.64% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Kamada

1D
-1.64%
1M
-8.17%
YTD
4.93%
6M
4.78%
1Y
2.89%
3Y*
12.16%
5Y*
5.76%
10Y*
7.64%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

KMDA Monthly Returns History

Based on dividend-adjusted daily data since May 31, 2013, KMDA's average daily return is +0.03%, while the average monthly return is +0.45%. At this rate, an investment would double in approximately 12.9 years.

Historically, 48% of months were positive and 52% were negative. The best month was Nov 2019 with a return of +42.1%, while the worst month was May 2014 at -44.0%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 9 months.

On a daily basis, KMDA closed higher 45% of trading days. The best single day was Dec 6, 2023 with a return of +20.9%, while the worst single day was May 16, 2014 at -34.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202617.85%4.57%-1.23%-2.40%-4.05%-7.94%4.93%
202510.51%2.38%-1.31%-2.12%5.87%13.14%-4.65%-6.36%0.29%-0.29%-3.18%5.37%19.25%
2024-6.37%9.95%-10.95%-6.95%0.96%-5.88%13.91%1.77%-6.61%6.89%2.61%3.40%-0.49%
202316.71%-7.69%7.52%0.32%3.65%9.21%-6.54%16.63%-7.13%-20.79%11.82%29.39%52.62%
2022-8.05%-8.26%-0.54%-2.72%-16.01%-0.00%13.75%-2.73%-9.62%-0.00%4.21%-14.68%-39.06%
2021-0.15%-5.10%0.81%-2.58%-2.65%-0.85%-6.53%-1.10%-1.49%7.74%9.11%5.62%1.54%

Benchmark Metrics

Kamada has an annualized alpha of -0.43%, beta of 0.57, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since May 31, 2013.

  • This stock participated in 93.82% of S&P 500 Index downside but only 39.51% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.57 may look defensive, but with R2 of 0.05 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-0.43%
Beta
0.57
0.05
Upside Capture
39.51%
Downside Capture
93.82%

Return for Risk

Risk / Return Rank

KMDA ranks 43 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


KMDA Risk / Return Rank: 4343
Overall Rank
KMDA Sharpe Ratio Rank: 4545
Sharpe Ratio Rank
KMDA Sortino Ratio Rank: 4040
Sortino Ratio Rank
KMDA Omega Ratio Rank: 4040
Omega Ratio Rank
KMDA Calmar Ratio Rank: 4646
Calmar Ratio Rank
KMDA Martin Ratio Rank: 4545
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Kamada (KMDA) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


KMDABenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.95

Sortino ratioReturn per unit of downside risk

-2.36

Omega ratioGain probability vs. loss probability

1.04

1.37

-0.32

Calmar ratioReturn relative to maximum drawdown

0.14

2.78

-2.64

Martin ratioReturn relative to average drawdown

0.26

12.44

-12.18

Dividends

Dividend History

Kamada provided a 3.48% dividend yield over the last twelve months, with an annual payout of $0.25 per share.


2.83%$0.00$0.05$0.10$0.15$0.202025
Dividends
Dividend Yield
PeriodTTM2025
Dividend$0.25$0.20

Dividend yield

3.48%2.83%

Monthly Dividends

The table displays the monthly dividend distributions for Kamada. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.25$0.00$0.00$0.00$0.25
2025$0.20$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.20

Dividend Yield & Payout


Dividend Yield

Kamada has a dividend yield of 3.48%, which is quite average when compared to the overall market.

Payout Ratio

Kamada has a payout ratio of 55.45%, which is quite average when compared to the overall market. This suggests that Kamada strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Kamada. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Kamada was 82.46%, occurring on Nov 25, 2014. The portfolio has not yet recovered.

The current Kamada drawdown is 56.46%.


Related event

Drawdown

Fall

Recovery

Underwater

2014 bear market2014
-82.46%Nov 2014
8mo 24d
12y 3moMar 2014 - now
2013 correction2013
-16.52%Oct 2013
15d2mo 19d
3mo 4dOct 2013 - Jan 2014
2014 correction2014
-12.82%Jan 2014
7d28d
1mo 5dJan 2014 - Feb 2014
2013 pullback2013
-8.30%Aug 2013
20d15d
1mo 5dAug 2013 - Sep 2013
2013 pullback2013
-6.83%Jun 2013
2d6d
8dJun 2013 - Jun 2013

Drawdown Indicators


KMDABenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-82.46%

-56.78%

-25.68%

Max Drawdown (1Y)

Largest decline over 1 year

-20.65%

-9.10%

-11.55%

Max Drawdown (3Y)

Largest decline over 3 years

-28.99%

-18.90%

-10.09%

Max Drawdown (5Y)

Largest decline over 5 years

-44.43%

-25.43%

-19.00%

Max Drawdown (10Y)

Largest decline over 10 years

-67.69%

-33.92%

-33.77%

Current Drawdown

Current decline from peak

-56.46%

-1.80%

-54.66%

Average Drawdown

Average peak-to-trough decline

-62.95%

-10.71%

-52.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.97%

2.03%

+8.94%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Kamada over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Kamada is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for KMDA, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, KMDA has a P/E ratio of 20.9. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for KMDA compared to other companies in the Drug Manufacturers - Specialty & Generic industry. KMDA currently has a PEG ratio of 6.3. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for KMDA relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, KMDA has a P/S ratio of 2.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for KMDA in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, KMDA has a P/B value of 1.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with KMDA

Add Kamada to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with KMDA